Park Joonhong, Yoo Han Mo, Jang Woori, Shin Soyoung, Kim Myungshin, Kim Yonggoo, Lee Seung-Woo, Kim Jeong Goo
Department of Laboratory Medicine Division of Gastrointestinal Surgery, Department of Surgery Division of Gastroenterology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Medicine (Baltimore). 2017 Jun;96(25):e7224. doi: 10.1097/MD.0000000000007224.
In studies of the molecular basis of gastric cancer (GC), microsatellite instability (MSI) is one of the key factors. Somatic mutations found in GC are expected to contribute to MSI-high (H) tumorigenesis. We estimated somatic mutation distribution according to MSI status in 52 matched pair GC samples using the Ion Torrent Ion S5 XL with the AmpliSeq Cancer Hotspot panel.Seventy-five (9.8%) somatic variants consisting of 34 hotspot mutations and 41 other likely pathogenic variants were identified in 34 GC samples. The TP53 mutations was most common (35%, 26/75), followed by EGFR (8%, 6/75), HNF1A (8%, 6/75), PIK3CA (8%, 6/75), and ERBB2 (5%, 4/75). To determine MSI status, 52 matched pair samples were estimated using 15 MSI markers. Thirty-nine MS stable (S), 5 MSI-low (L), and 8 MSI-H were classified. GCs with MSI-H tended to have more variants significantly compared with GCs with MS stable (MSS) and MSI-L (standardized J-T statistic = 3.161 for number of variants; P = .002). The mean number of all variants and hotspot mutations per tumor samples only in GCs with MSI-H were 3.9 (range, 1-6) and 1.1 (range, 0-3), respectively. Whereas, the mean number of all variants and hotspot mutations per tumor samples only in GCs with MSS/MSI-L were 1 (0-5)/0.8 (0-1) and 0.5 (0-3)/0.8 (0-1), respectively.In conclusion, GC with MSI-H harbored more mutations in genes that act as a tumor suppressor or oncogene compared to GC with MSS/MSI-L. This finding suggests that the accumulation of MSIs contributes to the genetic diversity and complexities of GC. In addition, targeted NGS approach allows for detection of common and also rare clinically actionable mutations and profiles of comutations in multiple patients simultaneously. Because GC shows distinctive patterns related to ethnics, further studies pertaining to different racial/ethnic groups or cancer types may reinforce our investigations.
在胃癌(GC)分子基础的研究中,微卫星不稳定性(MSI)是关键因素之一。预计在GC中发现的体细胞突变会导致微卫星高度不稳定(H)肿瘤的发生。我们使用配备AmpliSeq癌症热点分析试剂盒的Ion Torrent Ion S5 XL对52对匹配的GC样本,根据MSI状态估计体细胞突变分布。在34个GC样本中鉴定出75个(9.8%)体细胞变异,包括34个热点突变和41个其他可能的致病变异。TP53突变最为常见(35%,26/75),其次是EGFR(8%,6/75)、HNF1A(8%,6/75)、PIK3CA(8%,6/75)和ERBB2(5%,4/75)。为了确定MSI状态,使用15个MSI标记对52对匹配样本进行评估。分类出39个MS稳定(S)、5个MSI低(L)和8个MSI高(H)的样本。与MS稳定(MSS)和MSI低(L)的GC相比,MSI高的GC往往有更多的变异(变异数量的标准化J-T统计量 = 3.161;P = 0.002)。仅在MSI高的GC中,每个肿瘤样本的所有变异和热点突变的平均数分别为3.9(范围1 - 6)和1.1(范围0 - 3)。而仅在MSS/MSI-L 的GC中,每个肿瘤样本的所有变异和热点突变的平均数分别为1(0 - 5)/0.8(0 - 1)和0.5(0 - 3)/0.8(0 - 1)。总之,与MSS/MSI-L的GC相比,MSI高的GC在作为肿瘤抑制基因或癌基因的基因中存在更多突变。这一发现表明MSI的积累有助于GC的遗传多样性和复杂性。此外,靶向NGS方法能够同时检测多个患者中常见和罕见的临床可操作突变以及共突变谱。由于GC显示出与种族相关的独特模式,针对不同种族/民族群体或癌症类型的进一步研究可能会加强我们的调查。